 |
2009 Award Recipient
F. Peter Guengerich, Ph.D.
Harry Pearson Broquist Professor of Biochemistry and Director of the Center in Molecular Toxicology
Vanderbilt University School of Medicine
Nashville, TN
|
Dr. F. Peter Guengerich delivered his Award lecture entitled, "Mechanisms of Mutation: Interactions of DNA Polymerases with Carcinogen-Damaged DNA," during the 100th Annual Meeting 2009 in Denver, CO. Dr. Guengerich (center) received the Award from Dr. Perry D. Nisen (left), Senior Vice President, Cancer Research Oncology, GlaxoSmithKline, and Dr. Stephen S. Hecht (right), Selection Committee Chairperson.
- Learn more about the 2009 Recipient, Dr. F. Peter Guengerich.
- The webcast of the Award lecture may be accessed here.
- View the list of all past Recipients.
The Award and Lecture
The AACR and its Chemistry in Cancer Research Working Group established this Award in 2007 to recognize the importance of chemistry to advancements in cancer research. The Award will be given for outstanding, novel, and significant chemistry research, which has led to important contributions to the fields of basic cancer research; translational cancer research; cancer diagnosis; the prevention of cancer; or the treatment of patients with cancer. Such research may include, but is not limited to, drug discovery and design; structural biology; proteomics, metabolomics and biological mass spectrometry; chemical aspects of carcinogenesis; imaging agents and radiotherapeutics; and chemical biology.
The winner of the Fourth Annual AACR Award for Outstanding Achievement in Chemistry in Cancer Research will give a 50-minute lecture during the AACR 101st Annual Meeting 2010 in Washington, DC, USA (April 17-21, 2010), and will receive a commemorative plaque and a $10,000 honorarium.
Eligibility Criteria
- Candidacy is open to all researchers who are affiliated with any institution involved in cancer research, cancer medicine, or cancer-related biomedical science anywhere in the world. Such institutions include those in academia, industry, or government.
- The Award will be presented to an individual investigator. Two or more individuals may be selected to share the Award when their investigations are closely related in subject matter and have resulted in work worthy of an award.
- Institutions or organizations are not eligible for the Award.
- Selection of the Award winner will be made on the outstanding quality, novelty, and significance of the candidate's chemistry research and its important contributions to cancer research. No regard will be given to race, gender, nationality, geographic location, or religious or political views.
- Prior recipients of the AACR-Bruce F. Cain Memorial Award are not eligible to be nominated for research previously recognized by the Cain Award.
Nomination Process
Nominations for the 2010 Award will open in August of 2009. Nominations may be made by any scientist, whether an AACR member or nonmember, who is now or has been affiliated with any institution involved in cancer research, cancer medicine, or cancer-related biomedical science. Candidates may not nominate themselves.
Nominations must be submitted online at
https://proposalcentral.altum.com, no later than 4:00 p.m. United States Eastern Time on Thursday, October 15, 2009. Paper nominations will
not be accepted. The following materials must be submitted:
Nomination Letter, which must:
- be addressed to the Selection Committee, be written in English, and not exceed 1,000 words;
- specify the AACR Award for which the candidate is being nominated;
- contain a concise description of the candidate's outstanding achievements in clinical cancer research; publications supporting these contributions must be directly referenced within the letter; and
- contain a concise description of the impact of these contributions on the field.
Candidate's CV. The candidate's curriculum vitae in English, including a complete list of the candidate's publications.
Summary Statement. A statement of no more than 50 words summarizing the candidate's research accomplishments for which he or she is being nominated.
Preferred file formats are *.doc. The candidate's CV may be submitted as a .pdf file. Your nomination is not considered fully submitted until you receive a confirmation e-mail from the AACR; confirmations will be sent within two business days.
Nominators are asked to maintain the confidentiality of the nomination process and to refrain from informing the candidate about the nomination.
There is no restriction on the number of candidates that may be nominated by any individual scientist. There is no restriction on the number of nominators that may write nomination letters or that may sign a single nomination letter on behalf of a candidate.
Nomination Instructions
Will be available in August 2009.
Selection
Candidates will be considered by a Selection Committee of international cancer leaders appointed by the President of the AACR. The Committee will consider all nominations as they have been submitted; the Committee may not combine submitted nominations, add a new candidate to a submitted nomination, or otherwise make alterations to the submitted nominations. After careful deliberations by the Committee, its recommendations will be forwarded to the Executive Committee of the AACR for final consideration and decision. Selection of the Award winner will be made on the basis of the candidate's outstanding, novel, and significant chemistry research related to cancer. No regard will be given to age, race, gender, nationality, geographic location, or religious or political views.
The winner of the Fourth Annual AACR-CICR Award will be announced in January 2010.
Supporter
Generously supported by GlaxoSmithKline.
Questions?
Lauren Medvetz, Program Coordinator
+1 (267) 646-0689; lauren.medvetz@aacr.org
American Association for Cancer Research
17th Floor, 615 Chestnut Street
Philadelphia, PA 19106-4404